KACTUS to Exhibit at the 8th CAR-TCR Summit in Boston: Showcasing Innovative MHC & TCR Products & Services

By Mallory Griffin


KACTUS is excited to announce that we will be attending the 8th CAR-TCR Summit in Boston from August 29 to September 1, 2023. As the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers, this event is the perfect opportunity for us to showcase our innovative products and services.


At booth #24, attendees can learn more about our Peptide-MHC Complexes, which are available in both catalog and custom options. These mammalian-expressed Peptide-MHCs have natural folding and glycosylation patterns for optimal bioactivity. Browse our 150+ Peptide-MHC catalog products or request a custom Peptide-MHC with your choice of monomer/tetramer, biotinylation, fluorescent labeling, allele, and peptide.

Peptide-Ready MHC

Learn more about one of newest product lines, Peptide-Ready MHCs (prMHC), available as in-stock catalog products or can be customized to meet specific research needs. Peptide-Ready MHCs are a ready-to-use loading system for binding your own neoantigen peptide. Create your own Peptide-MHC in-house for more versatility or use of proprietary neoantigen-peptides. 

Custom TCR-Expression Services

Request our Custom TCR-Expression Services, to receive a customized soluble TCR that meets your specific research needs. Our team also offers SPR analysis of TCR/MHC binding interactions. Contact us today to learn more. 

Attendees who visit our booth can also pick up gifts and swag, including t-shirts. We look forward to meeting with researchers and industry experts to discuss the latest developments in the field of cell therapy.

Event details:

  • Location: Hynes Convention Center, Boston MA
  • Date: August 29 - September 1, 2023
  • KACTUS Booth #24

Don't miss out on this exciting opportunity to learn more about KACTUS and our innovative products and services. We hope to see you there!